The essentials

The Epstein-Barr virus (EBV) is a herpes-family virus that about 9 in 10 adults carry, usually without ever knowing it. A first infection is often silent in children and can cause mononucleosis in teens and young adults; the virus then stays dormant in the body for life. Blood tests read antibodies against three parts of the virus (VCA, EBNA and early antigen) to tell a never-infected, recently infected or long-past infected person apart.

What is the Epstein-Barr virus, at a glance?

  • Medical name: Epstein-Barr virus, also called human herpesvirus 4 and shortened to EBV[1].
  • How common: most people are infected at some point, often in childhood. About 9 out of 10 adults have antibodies showing a current or past infection[1].
  • Lifelong guest: after the first infection, the virus becomes latent (inactive) and can occasionally reactivate[1].
  • Key tests: EBV antibody panel (VCA IgM, VCA IgG, EBNA IgG, early antigen IgG), the rapid monospot test and, in special cases, EBV DNA by PCR[3][7].

What are the symptoms of Epstein-Barr virus?

It depends mostly on age at the first infection. In young children, EBV usually causes no symptoms, or symptoms that look like any brief childhood illness[1]. In teens and young adults, at least 1 in 4 infections turns into infectious mononucleosis, most often between 15 and 24 years of age[5][8].

  • Typical signs: fatigue, fever, an inflamed throat, swollen lymph nodes in the neck, an enlarged spleen, a swollen liver and sometimes a rash[1].
  • Slow start: symptoms appear about six weeks after contact, much later than with the flu[6].
  • Duration: most people feel better in 2 to 4 weeks, but tiredness can last several weeks or even months[1].
  • Reactivation: when the dormant virus wakes up, it usually causes no symptoms. People with a weakened immune system are more likely to become ill[1].

White patches on the throat can also come from bacteria: see white spots on the tonsils.

When should I see a doctor about EBV?

When to see a doctor

  • Emergency: call 911 for sudden, sharp pain in the upper left belly (a possible ruptured spleen), or for trouble breathing or swallowing because of very swollen tonsils. Airway obstruction is the most common reason children with mono are hospitalized[8].
  • Within 24 to 48 hours for yellow skin or eyes, a stiff neck, weakness or numbness, unusual bruising, or a fever after an organ or stem cell transplant. EBV can affect the nerves, the blood and the liver[2].
  • At your next appointment for an EBV antibody result you do not understand, or for fatigue lasting more than a few months.

How do you catch EBV, and who is at risk?

EBV spreads mainly through saliva: kissing, sharing drinks, food, cups, utensils or toothbrushes, and toys a child has drooled on. It can also pass through blood and semen during sexual contact, blood transfusions and organ transplants[1]. A newly infected person can spread the virus for weeks, even before having symptoms[1].

  • Common A silent first infection in childhood, which leaves lifelong antibodies[1].
  • Common A first infection in adolescence through deep kissing, the main source identified in teens[6].
  • Possible More severe illness in people with a weakened immune system, for example after a transplant or with untreated HIV infection (AIDS)[2][12].
  • Rare Complications such as meningitis, encephalitis, Guillain-Barré syndrome, myocarditis or hemophagocytic lymphohistiocytosis (an extreme immune reaction)[2].
  • Rare Chronic active EBV disease, in which the body cannot control the virus: fever, swollen nodes, a large spleen and very high EBV DNA in the blood[11].

How is EBV diagnosed? Reading VCA, EBNA and early antigen antibodies

Typical mono is often diagnosed from symptoms alone. Antibody tests help when the illness is atypical, when the monospot is negative, or when another EBV-related disease is suspected[3]. The doctor may add a complete blood count (with lymphocytes) and liver tests such as ALT, and a throat swab to rule out strep throat[5].

Each antibody appears and fades on its own timetable[3]:

  • VCA IgM (viral capsid antigen, early antibody): appears early and usually disappears within 4 to 6 weeks.
  • VCA IgG: appears during the acute phase, peaks 2 to 4 weeks after onset, then stays for life.
  • EA-D IgG (early antigen): appears during the acute illness and usually becomes undetectable after 3 to 6 months, but about 20% of healthy people keep it for years.
  • EBNA IgG (nuclear antigen): absent at first, appears 2 to 4 months after symptoms start, then stays for life.

A fictitious report from a 19-year-old with 10 days of fever and sore throat:

Fictitious example of an EBV antibody panel (United States format)
TestResultReference rangeFlag
EBV VCA IgM antibody98.4 U/mLNegative: <36.0; equivocal: 36.0-43.9; positive: >43.9POS
EBV VCA IgG antibody215.0 U/mLNegative: <18.0; equivocal: 18.0-21.9; positive: >21.9POS
EBV nuclear antigen (EBNA) IgG<5.0 U/mLNegative: <18.0; equivocal: 18.0-21.9; positive: >21.9NEG
EBV early antigen D IgG31.6 U/mLNegative: <9.0; equivocal: 9.0-10.9; positive: >10.9POS
  1. Cut-offs: they vary between assays; only the ranges on your own report apply.
  2. VCA IgM positive and EBNA negative: the pattern of a primary (new) infection[3].
  3. VCA IgG positive: expected from the acute phase onward; a high value alone does not date the infection, because high levels can persist for years[3].
  4. EA-D IgG positive: supports an active infection, but is never read alone, since some healthy people keep it for years[3].

Four EBV antibodies, each with its own cut-offs, next to a blood count and liver tests? BloodSense explains every line of your complete report in plain words and helps you prepare questions for your doctor.

Explain my EBV test results
How the three main EBV antibody results are usually read
VCA IgMVCA IgGEBNA IgGUsual reading
NegativeNegativeNegativeNever infected: susceptible to EBV[3].
PositivePositive or negativeNegativePrimary (recent) infection[3].
NegativePositivePositivePast infection, months to years ago: the most frequent adult result[3].
PositivePositivePositiveLate phase of a recent infection, or a reactivation; extra tests may help[7].
NegativePositiveNegativeUnclear: an early infection or an old one; IgG avidity or immunoblot can settle it[7].
NegativeNegativePositiveIsolated EBNA IgG: can raise doubts and may need confirmation by another method[7].

Monospot (heterophile antibody test): results come back within an hour, but it misses about 1 in 4 cases in the first week of illness and is often negative in young children[8][3]. A positive monospot suggests typical mono but does not prove EBV[3].

Too early to tell: in the first days, antibody levels can still be low, so the test is sometimes repeated 10 days to 2 weeks later[4]. On a report, "reactive" simply means "positive": see reactive and non-reactive results.

What does a positive EBV IgG mean?

On its own, a positive VCA IgG or EBNA IgG almost always means you met the virus in the past, like 9 out of 10 adults[1]. It is not a disease and does not, by itself, explain current symptoms. The CDC notes that high antibody levels can last for years and do not prove a recent infection, and that comparing two samples a few weeks apart does not help separate a recent infection from an old one[3]. For the general meaning of these antibody classes, see our pages on IgG and IgM.

Can Epstein-Barr reactivate, and how is it followed up?

Yes. The latent virus can reactivate, usually without symptoms, and a person can then pass it on even years after the first infection[1]. Antibody tests are a poor tool to "diagnose reactivation" in a healthy person: all three antibodies can be positive both late in a recent infection and during a reactivation[7], and early antigen antibodies persist for years in some healthy people[3].

  • After mono: no repeat EBV test is needed once symptoms resolve. If someone is ill for more than 6 months without a laboratory-confirmed EBV infection, the CDC advises looking for other causes, including chronic fatigue syndrome[3].
  • Before and after a transplant: EBV antibodies are checked before transplantation, because an EBV-negative recipient faces the highest risk. EBV DNA (viral load by PCR) is then measured in the blood at intervals set by the transplant team[12].

Is Epstein-Barr linked to cancer and multiple sclerosis?

EBV is linked to several cancers: Burkitt lymphoma, nasopharyngeal carcinoma (upper throat), Hodgkin and non-Hodgkin lymphoma and post-transplant lymphoproliferative disorder[2]. A 2022 review estimated that EBV-related forms of six cancers, including some stomach cancers, caused 239,700 to 357,900 new cases and 137,900 to 208,700 deaths worldwide in 2020[9]. These cancers remain rare compared with the number of people who carry the virus.

In a cohort of more than 10 million young US military personnel, the risk of multiple sclerosis rose 32-fold after EBV infection, while infection with the similarly spread cytomegalovirus did not raise it[10]. EBV now looks like a necessary trigger, but the immense majority of carriers never develop MS. No EBV test is used to screen for MS.

Where nasopharyngeal cancer is common, plasma EBV DNA can serve for screening: in a Hong Kong study of 20,174 people, it found 71% of cancers at stage I or II, against 20% in a historical group[13].

How is Epstein-Barr virus treated?

There is no specific treatment for an ordinary EBV infection. Care relieves symptoms: fluids, rest and over-the-counter medicine for pain and fever[1].

  • Antivirals and steroids: they do not shorten mono or make it milder[8].
  • Sport: physical activity in the first 3 weeks may increase the risk of spleen rupture, so contact sports are avoided during that time[8].
  • After a transplant: a rising viral load is mainly managed by lowering the anti-rejection treatment, decided by the specialist team[12].
  • Chronic active EBV disease: the only proven effective treatment is a hematopoietic stem cell transplant[11].

How can I prevent EBV?

There is no vaccine yet. Reducing contact with an infected person's saliva (kissing, shared drinks, food and personal items) lowers the risk[1], but the virus is so common that most people meet it eventually. An mRNA vaccine candidate (mRNA-1189) is being tested in a phase 1/2 trial in healthy people aged 10 to 30[14].

Questions to ask your doctor

  1. Does my antibody pattern mean a never-infected, recent or past EBV infection?
  2. Could another virus, such as cytomegalovirus, explain my symptoms instead?
  3. Do I need to avoid sport, and for how long, given the size of my spleen?
  4. Is a repeat antibody test or an EBV DNA test useful in my situation?

Frequently asked questions

Does Epstein-Barr ever go away?

No. After the first infection, the virus stays dormant for life. This is normal and harmless for the vast majority of people[1].

Is EBV a sexually transmitted infection?

Not mainly. It spreads above all through saliva, although semen and blood can also carry it[1].

Can I get mono from EBV twice?

EBV stays in the body after the first infection, so a second mono-like illness more often comes from another germ, such as cytomegalovirus (CMV), which causes a very similar picture[5].

Should I test for EBV if I am always tired?

A positive IgG is expected in most adults and does not explain fatigue. Testing makes sense when a doctor suspects a recent infection; long-lasting fatigue needs a broader check-up[3].

  1. Centers for Disease Control and Prevention. About Epstein-Barr virus (EBV). May 9, 2024. cdc.gov (accessed November 14, 2026)
  2. Centers for Disease Control and Prevention. Clinical overview of Epstein-Barr virus (EBV). April 10, 2024. cdc.gov (accessed November 14, 2026)
  3. Centers for Disease Control and Prevention. Laboratory testing for Epstein-Barr virus (EBV). April 10, 2024. cdc.gov (accessed November 14, 2026)
  4. MedlinePlus Medical Encyclopedia. Epstein-Barr virus antibody test. Reviewed August 5, 2025. US National Library of Medicine. medlineplus.gov (accessed November 14, 2026)
  5. MedlinePlus. Mononucleosis (mono) tests. US National Library of Medicine. medlineplus.gov (accessed November 14, 2026)
  6. Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84-92. doi:10.1016/j.jcv.2018.03.001 (accessed November 14, 2026)
  7. De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;1(1):31-43. doi:10.5501/wjv.v1.i1.31 (accessed November 14, 2026)
  8. Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91(6):372-376. aafp.org (accessed November 14, 2026)
  9. Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2022;148(1):31-46. doi:10.1007/s00432-021-03824-y (accessed November 14, 2026)
  10. Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296-301. doi:10.1126/science.abj8222 (accessed November 14, 2026)
  11. Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867. doi:10.3389/fimmu.2017.01867 (accessed November 14, 2026)
  12. Allen UD, Preiksaitis JK; AST Infectious Diseases Community of Practice. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13652. doi:10.1111/ctr.13652 (accessed November 14, 2026)
  13. Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377(6):513-522. doi:10.1056/NEJMoa1701717 (accessed November 14, 2026)
  14. ClinicalTrials.gov. A study of an Epstein-Barr virus (EBV) candidate vaccine, mRNA-1189, in 10- to 30-year-old healthy adolescents and adults (NCT05164094). clinicaltrials.gov (accessed November 14, 2026)

This page is general information. It does not replace the advice of a doctor, who interprets your antibody results with your symptoms, age, history and examination.